(Q39922022)

15 September 2017

title

Cost effectiveness of 5-alpha reductase inhibitors for the prevention of prostate cancer in multiple patient populations (English)

1 reference

15 September 2017

1 reference

1 reference

Stephanie R Earnshaw

1

1 reference

15 September 2017

Cheryl L McDade

2

1 reference

15 September 2017

Libby K Black

3

1 reference

15 September 2017

Christopher F Bell

4

1 reference

15 September 2017

Michael W Kattan

5

1 reference

15 September 2017

publication date

1 January 2010

1 reference

15 September 2017

1 reference

15 September 2017

volume

28

1 reference

15 September 2017

issue

6

1 reference

15 September 2017

page(s)

489-505

1 reference

https://scigraph.springernature.com/pub.10.2165/11531780-000000000-00000

15 September 2017

exact match

0 references

cites work

Early detection of prostate cancer. Part II: Estimating the risks, benefits, and costs. American College of Physicians

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11531780-000000000-00000

Chemoprevention of prostate cancer in men at high risk: rationale and design of the reduction by dutasteride of prostate cancer events (REDUCE) trial

21 January 2018

1 reference

12 December 2020

Economic analysis of finasteride: a model-based approach using data from the Proscar Long-Term Efficacy and Safety Study

1 reference

12 December 2020

Cost comparison of radical retropubic and radical perineal prostatectomy: single institution experience

1 reference

12 December 2020

Prevention of hormone-related cancers: prostate cancer

1 reference

12 December 2020

A comparison of the cost of various treatment methods for early cancer of the prostate

1 reference

12 December 2020

The story of the European Randomized Study of Screening for Prostate Cancer

1 reference

12 December 2020

Efficacy and safety of dutasteride in the four-year treatment of men with benign prostatic hyperplasia

1 reference

12 December 2020

The cost of prostate cancer chemoprevention: a decision analysis model

1 reference

12 December 2020

Utility scores for chronic conditions in a community-dwelling population

1 reference

12 December 2020

The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. Finasteride Long-Term Efficacy and Safety Study Group

1 reference

12 December 2020

An examination of treatment patterns and costs of care among patients with benign prostatic hyperplasia.

1 reference

12 December 2020

Lesions predictive for prostate cancer in a screened population: First and second screening round findings

1 reference

12 December 2020

Estimating the risk of long-term erectile, urinary and bowel symptoms resulting from prostate cancer treatment

1 reference

12 December 2020

Use of cost-effectiveness analysis in health-care resource allocation decision-making: how are cost-effectiveness thresholds expected to emerge?

1 reference

12 December 2020

Distribution of prostate specific antigen (PSA) and percentage free PSA in a contemporary screening cohort with no evidence of prostate cancer.

1 reference

12 December 2020

Followup interval prostate biopsy 3 years after diagnosis of high grade prostatic intraepithelial neoplasia is associated with high likelihood of prostate cancer, independent of change in prostate specific antigen levels

1 reference

12 December 2020

Relationship of first-year costs of treating localized prostate cancer to initial choice of therapy and stage at diagnosis: results from the CAPSURE database

1 reference

12 December 2020

Assessing individual risk for prostate cancer

1 reference

12 December 2020

Defining increased future risk for prostate cancer: evidence from a population based screening cohort.

1 reference

12 December 2020

The influence of finasteride on the development of prostate cancer

1 reference

12 December 2020

Prostate cancer detection in men with prior high grade prostatic intraepithelial neoplasia or atypical prostate biopsy

1 reference

12 December 2020

The prevalence of prostatism: a population-based survey of urinary symptoms

1 reference

12 December 2020

Willingness to pay for a quality-adjusted life year: in search of a standard

1 reference

12 December 2020

Cost-efficient radical prostatectomy with a clinical care path.

1 reference

12 December 2020

Cost effectiveness of microwave thermotherapy in patients with benign prostatic hyperplasia: part I-methods

1 reference

12 December 2020

Cost-effectiveness of prostate cancer chemoprevention: a quality of life-years analysis

1 reference

12 December 2020

Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy

1 reference

12 December 2020

Efficacy and safety of a dual inhibitor of 5-alpha-reductase types 1 and 2 (dutasteride) in men with benign prostatic hyperplasia

1 reference

12 December 2020

Screening and prostate-cancer mortality in a randomized European study

1 reference

12 December 2020

Predicting cancer following a diagnosis of high-grade prostatic intraepithelial neoplasia on needle biopsy: data on men with more than one follow-up biopsy

1 reference

12 December 2020

Comparing the costs of radiation therapy and radical prostatectomy for the initial treatment of early-stage prostate cancer

1 reference

12 December 2020

Prospective development of a cost-efficient program for radical retropubic prostatectomy

1 reference

12 December 2020

A review and meta-analysis of prostate cancer utilities.

1 reference

12 December 2020

Comparison of the hospital costs for radical prostatectomy and cryosurgical ablation of the prostate

1 reference

12 December 2020

Lifetime implications and cost-effectiveness of using finasteride to prevent prostate cancer

1 reference

12 December 2020

Finasteride significantly reduces acute urinary retention and need for surgery in patients with symptomatic benign prostatic hyperplasia

1 reference

12 December 2020

10.2165/11531780-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

15 September 2017

1033088969

0 references

Fatcat ID

release_65j7l6kbhnczjpx2iyocc2albi

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/65j7l6kbhnczjpx2iyocc2albi

24 November 2022

mapped directly with Wikidata item

1 reference